2',3'-O-异丙叉肌苷是一种医药中间体,可用于制备卡培他滨。卡培他滨(Capecitabine)是5-氟尿嘧啶的前药。该化合物本身无细胞毒性,在体内酶的作用下经三步酶解代谢为5-FU(5-氟尿嘧啶),从而发挥抗肿瘤作用。
制备取100克肌苷(0.368摩尔),加入400毫升丙酮,搅拌下慢慢加入40毫升浓硫酸,并加热至回流。待固体完全溶解后,加入100克无水硫酸铜并继续回流5小时。通过TLC跟踪反应进程,确保反应完成。随后,用160克碳酸钠中和反应物,去除无机盐,用丙酮洗涤,合并滤液,并在减压下蒸出溶剂。将残渣加入200毫升60%乙醇中热溶解,趁热过滤并冷藏滤液,得到淡黄色晶体96克,熔点为192~196℃,收率83.7%。
| 中文名称 | 英文名称 | CAS号 | 化学式 | 分子量 |
|---|---|---|---|---|
| 2',3'-异丙叉腺苷 | 2',3'-isopropylidene adenosine | 362-75-4 | C13H17N5O4 | 307.309 |
| 肌苷 | inosine | 58-63-9 | C10H12N4O5 | 268.229 |
| 中文名称 | 英文名称 | CAS号 | 化学式 | 分子量 |
|---|---|---|---|---|
| —— | 1-(5-hydroxypentyl)-2',3'-O-isopropylideneinosine | 65370-94-7 | C18H26N4O6 | 394.428 |
| —— | 5'-Chlor-5'-deoxy-2',3'-O-isopropylideninosin | 21017-03-8 | C13H15ClN4O4 | 326.739 |
| —— | O2',O3'-isopropylidene-[5']inosinic acid | 2607-07-0 | C13H17N4O8P | 388.274 |
| —— | 2',3'-O-isopropylidene-5'-O-(sulfamoyl)inosine | 939794-82-8 | C13H17N5O7S | 387.373 |
| —— | 5'-amino-5'-deoxy-2',3'-isopropylidene-inosine | 471923-07-6 | C13H17N5O4 | 307.309 |
| —— | 5'-O-TBDMS-2',3'-O-isopropylideneinosine | —— | C19H30N4O5Si | 422.556 |
| 2',3'-O-异亚丙基肌苷-5'-甲酸 | 2',3'-O-isopropylideneinosine-5'-carboxylic acid | 28440-13-3 | C13H14N4O6 | 322.277 |
| —— | 2, 3-O-isopropylidene-1-N-pivaloyloxymethylinosine | 1259953-68-8 | C19H26N4O7 | 422.438 |
| —— | 5'-azido-5'-deoxy-2',3'-O-isopropylideneinosine | —— | C13H15N7O4 | 333.307 |
| —— | 2',3'-isopropylidene-5'-O-[(diethylphosphono)acetyl]-inosine | 1392420-13-1 | C19H27N4O9P | 486.419 |
| —— | 5'-O-diphenylphosphoryl-2',3'-O-isopropylideneinosine | —— | C25H25N4O8P | 540.469 |
| —— | 5'-O-Tosyl-2',3'-O-isopropyliden-inosin | 53186-64-4 | C20H22N4O7S | 462.483 |
| —— | 5'-O-(monomethoxytrityl)-2',3'-O-isopropylideneinosine | 239080-20-7 | C33H32N4O6 | 580.64 |
| 6-氯-9-beta-D-(2,3-异亚丙基)呋喃核糖基嘌呤 | 6-chloro-9-(2,3-O-isopropylidene-β-D-ribofuranosyl)-9H-purine | 39824-26-5 | C13H15ClN4O4 | 326.739 |
| —— | 1-benzyl-5'-O-benzyl-2',3'-O-isopropylideneinosine | 911430-77-8 | C27H28N4O5 | 488.543 |
| —— | (3aS,4S,6R,6aR)-N-ethyl-2,2-dimethyl-6-(6-oxo-1,6-dihydro-9H-purin-9-yl)tetrahydrofuro[3,4-d][1,3]dioxole-4-carboxamide | —— | C15H19N5O5 | 349.346 |
| —— | 5'-O-carboxymethylinosine | 76768-33-7 | C12H14N4O7 | 326.266 |
| —— | 1-[5-O-(dianilinophosphoryl)pentyl]-2',3'-O-isopropylideneinosine | 516509-94-7 | C30H37N6O7P | 624.634 |
| —— | 2',3'-isopropylidene-5'-deoxy-5'-[(diethylphosphonoacetyl)amino]-inosine | 1392420-15-3 | C19H28N5O8P | 485.434 |
| —— | 5'-O-(dianilinophosphoryl)-1-[5-O-(dianilinophosphoryl)pentyl]-2',3'-O-isopropylideneinosine | 516509-89-0 | C42H48N8O8P2 | 854.839 |
| —— | 1-deoxy-1-(1,6-dihydro-6-oxo-9H-purin-9-yl)-β-D-ribofuranuronic acid | 15475-13-5 | C10H10N4O6 | 282.213 |
| —— | 5'-O-[(diethylphosphono)acetyl]-inosine | 1392420-14-2 | C16H23N4O9P | 446.354 |
| —— | inosyl-6'-pyrrole-3-carboxylate | —— |